Edward H Myles Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Edward H Myles.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Edward H Myles. Edward H Myles is a Chief Financial Officer in AMAG PHARMACEUTICALS INC. ($AVM) and a COO & CFO in AMAG PHARMACEUTICALS, INC. ($AVM) and a Vice President of Finance/CFO in PRESSURE BIOSCIENCES INC ($PBIO) and a VP of Finance & CFO in PRESSURE BIOSCIENCES INC ($PBIO) and a COO & CFO in Ocata Therapeutics, Inc. ($ACTC) and a Chief Financial Officer in Scholar Rock Holding Corp ($SRRK) and a Director in Scholar Rock Holding Corp ($SRRK).
Address: 40 BRENTON ROAD SWANSEA 02777 MA
Companies in which Edward H Myles is an Insider
AMAG PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Edward H Myles: COO & CFO, Chief Financial Officer
Holdings: 98,659 shares
Latest Transaction: Mar 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ocata Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Edward H Myles: COO & CFO
Holdings: 0 shares
Latest Transaction: Feb 11 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PRESSURE BIOSCIENCES INC
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Edward H Myles: VP of Finance & CFO, Vice President of Finance/CFO
Holdings: 2,000 shares
Current Value: $320
Latest Transaction: Sep 07 2006
$PBIO Market Capitalization: $4.94M
$PBIO Previous Close: $0.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Scholar Rock Holding Corp
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Edward H Myles: Chief Financial Officer, Director
Holdings: 24,150 shares
Latest Transaction: Feb 03 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Edward H Myles
Sentiment: All, AVM, ACTC, PBIO, SRRK
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | SRRK | Scholar Rock Holdi ... | Myles Edward H | Chief Financial Off ... | Option Exercise | A | 58.93 | 80,500 | 4,743,865 | 346,301 | |
| Feb 03 2021 | SRRK | Scholar Rock Holdi ... | Myles Edward H | Chief Financial Off ... | Grant | A | 0.00 | 24,150 | 0 | 24,150 | 0 to 24.2 K |
| Jul 17 2020 | SRRK | Scholar Rock Holdi ... | Myles Edward H | Chief Financial Off ... | Option Exercise | A | 13.83 | 250,000 | 3,457,500 | 250,000 | |
| Jun 18 2020 | SRRK | Scholar Rock Holdi ... | Myles Edward H | Director | Option Exercise | A | 17.65 | 13,000 | 229,450 | 13,000 | |
| Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | COO & CFO | Option Exercise | A | 7.27 | 45,000 | 327,150 | 45,000 | |
| Mar 12 2020 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | COO & CFO | Grant | A | 0.00 | 30,000 | 0 | 98,659 | 68.7 K to 98.7 K (+43.69 %) |
| Mar 04 2020 | AVM | AMAG PHARMACEUTICA ... | Myles Edward H | COO & CFO | Payment of Exercise | F | 7.75 | 1,021 | 7,913 | 68,659 | 69.7 K to 68.7 K (-1.47 %) |